MedTrace Logo

Robot-Assisted Intelligent Rehabilitation Treatment for Methamphetamine Use Disorders.

NCT04531384 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2022-12-29

No results posted yet for this study

Summary

The purpose of this research is to evaluate the efficacy and safety of Robot-assisted rehabilitation intelligent system as a virtual stand-alone treatment, delivered with minimal clinical monitoring compared with treatment as usual in methamphetamine (MA) use disorders.

Conditions

  • Amphetamine Addiction

Interventions

DEVICE

robot-assisted rehabilitation intelligent treatment

robot-assisted rehabilitation psychotherapy

OTHER

standard psychotherapy treatment

standard treatment at the compulsory isolated detoxification centers and non-compulsory isolated detoxification institutions

Sponsors & Collaborators

  • Shanghai Mental Health Center

    lead OTHER

Principal Investigators

  • Min Zhao · Shanghai Mental Health Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-01
Primary Completion
2022-12-31
Completion
2022-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04531384 on ClinicalTrials.gov